Interleukin-2

1
Assets
1
Companies

Target Biology

Competitive Landscape

Asset Company Stage Mechanism Lead Indication Ownership
TransCon_IL-2_b_g ASND Phase 2 TransCon prodrug releasing IL-2

Companies

ASND 1 asset(s)
Phase 2
← Back to All Targets